ArticleEpidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?Author:William Lewis, MDPublish date: December 30, 2022Symmetrical drug-related intertriginous and flexural exanthema is an uncommon but increasingly recognized cutaneous adverse event of epidermal grow...Read More
ArticleCutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the PandemicAuthor:William Lewis, MDPublish date: April 7, 2021Cutaneous manifestations of COVID-19 may reflect the range of host immunologic responses to SARS-CoV-2.Read More
